Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03275285
Title Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients (IKEMA)
Acronym IKEMA
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Sanofi
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | TUR | NZL | ITA | HUN | GRC | GBR | FRA | ESP | CZE | CAN | BRA | AUS


No variant requirements are available.